Evaluation of a new, rapid, and quantitative D-Dimer test in patients with suspected pulmonary embolism.

Archive ouverte

Oger, Emmanuel | Leroyer, Christophe | Bressollette, Luc | Nonent, Michel | Le Moigne, Emmanuelle | Bizais, Yves | Amiral, J. | Grimaux, M. | Clavier, Jean | Ill, Patrick | Abgrall, Jean-François | Mottier, Dominique

Edité par CCSD ; American Thoracic Society -

International audience. Previous studies have suggested the utility of D-Dimer ELISA assays in eliminating a diagnosis of pulmonary embolism (PE). Our objectives were to evaluate the performance of a new, rapid, quantitative, and automated Liatest D-Dimer Assay in patients with suspected PE. Three hundred eighty-six consecutive patients referred to our institution between March 1992 and December 1996 for clinically suspected PE, with recent clinical signs not exceeding 1 wk, were included in this study. Diagnosis of PE was based on clinical evaluation, radionuclide lung imaging, lower limb examination, and, when required, pulmonary angiography. D-Dimer performances, for both Liatest D-Dimer and standard D-Dimer ELISA (Asserachrom DDi), assays, were assessed at the end of the study. Among the 386 patients tested, 146 (37.8%) were classified as PE-positive. Liatest D-Dimer assay had a 100% sensitivity (95% confidence interval, 97 to 100%) and a negative predictive value of 100% (95% confidence interval, 94 to 100%). A normal result, below the cutoff of 500 ng/ml, occurred in 83 of the 386 (21%) patients. There was a strong agreement between Liatest D-Dimer and Asserachrom DDi analyses. These findings suggest that this rapid, quantitative, and automated D-Dimer assay provides a useful diagnostic tool for the clinician with regard to exclusion of PE.

Consulter en ligne

Suggestions

Du même auteur

Evaluation of a new rapid D-dimer assay for clinically suspected deep venous thrombosis (Liatest D-dimer).

Archive ouverte | Escoffre-Barbe, Martine | CCSD

International audience. In previous studies, enzyme-linked immunosorbent assays (ELISA) for plasma D-dimer analysis have demonstrated high sensitivity, suggesting their potential usefulness in excluding deep venous ...

Early versus delayed introduction of oral vitamin K antagonists in combination with low-molecular-weight heparin in the treatment of deep vein thrombosis. a randomized clinical trial. The ANTENOX Study Group.

Archive ouverte | Leroyer, Christophe | CCSD

International audience. Objective: To compare oral anticoagulant treatment (fluindione) started on either the 1st or the 10th day of a low-molecular-weight heparin (enoxaparin) treatment for deep vein thrombosis con...

Assessment of activated protein C resistance using a new and rapid venom-based test: STA Staclot APC-R.

Archive ouverte | Oger, Emmanuel | CCSD

International audience. Activated protein C (APC) resistance is related to a single point mutation in the factor V gene (FV:Q506) and appears to be the most common inherited risk factor for venous thromboembolism. A...

Chargement des enrichissements...